Payment; Reports. Within forty-five (45) days after the end of each calendar quarter during the Term, the Company shall provide the Licensor, along with the Royalties, with a report stating the Company’s Net Sales, Gross Margin, revenues from sublicenses made by the Company to third parties and, if applicable, all information used to establish the pro-rata calculation should the Company sell a Formulation, the whole for that calendar quarter by the Company. Such report shall also indicate the quantity of Licensed Products sold by the Company during such calendar quarter. The Company shall provide the reports due to the Licensor at the address set forth in Section 14.14.
Appears in 8 contracts
Samples: Technology License Agreement (Acasti Pharma Inc.), Technology License Agreement (Acasti Pharma Inc.), Technology License Agreement (Neptune Technologies & Bioressources Inc.)
